-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$76.254.24% Upside
Recent Analyst Forecasts and Stock Ratings
Insmed Incorporated Frequently Asked Questions
-
What analysts cover Insmed Incorporated?
Insmed Incorporated has been rated by research analysts at Mizuho Securities, Wells Fargo, Guggenheim, Truist Financial, Barclays, Evercore ISI in the past 90 days.